Exagen Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.04

+0.01 (+0.10%)

As of Nov 14, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +910.3% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $5.04

Current
$5.04

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

643.7%

Low target

Base Case

$50.92

+910.3%

Avg target

Bull Case

$70.07

+1,290.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$9.74

-48.2% from high

52-Week Low

$2.59

+94.6% from low

Target vs 52W High

$50.92

+423.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%